Chris Freeman is Chief Commercial Officer of Guardant Health, Inc.. Currently has a direct ownership of 25,769 shares of GH, which is worth approximately $850,377. The most recent transaction as insider was on Jul 01, 2024, when has been sold 758 shares (Common Stock) at a price of $28.26 per share, resulting in proceeds of $21,421. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K
61.35% 3M change
234.92% 12M change
Total Value Held $850,377

Chris Freeman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
SELL
Payment of exercise price or tax liability
$21,421 $28.26 p/Share
758 Reduced 2.86%
25,769 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
-
1,928 Added 6.78%
26,527 Common Stock
Jun 15 2024
SELL
Payment of exercise price or tax liability
$86,702 $30.21 p/Share
2,870 Reduced 10.45%
24,599 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
10,402 Added 27.47%
27,469 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$10,752 $20.25 p/Share
531 Reduced 3.22%
15,971 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
-
1,929 Added 10.47%
16,502 Common Stock
Jan 01 2024
SELL
Payment of exercise price or tax liability
$17,149 $27.05 p/Share
634 Reduced 4.17%
14,573 Common Stock
Jan 01 2024
BUY
Exercise of conversion of derivative security
-
1,928 Added 11.25%
15,207 Common Stock
Oct 01 2023
SELL
Payment of exercise price or tax liability
$63,073 $29.64 p/Share
2,128 Reduced 13.81%
13,279 Common Stock
Oct 01 2023
BUY
Exercise of conversion of derivative security
-
7,713 Added 33.36%
15,407 Common Stock
Jun 15 2023
SELL
Payment of exercise price or tax liability
$50,959 $37.86 p/Share
1,346 Reduced 14.89%
7,694 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
4,879 Added 35.05%
9,040 Common Stock
Jun 15 2022
SELL
Payment of exercise price or tax liability
$64,853 $38.42 p/Share
1,688 Reduced 34.6%
3,191 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
-
4,879 Added 50.0%
4,879 Common Stock
CF

Chris Freeman

Chief Commercial Officer
Redwood City, CA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Track Activities on GH